MLORX | MLPLX | MLORX / MLPLX | |
Total Expense Ratio | 1.40 | 8.06 | 17% |
Annual Report Gross Expense Ratio | 1.80 | 8.06 | 22% |
Fund Existence | 11 years | 13 years | - |
Gain YTD | 4.771 | 4.039 | 118% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 117M | 305M | 38% |
Annual Yield % from dividends | 4.74 | 5.32 | 89% |
Returns for 1 year | 6.41 | 27.34 | 23% |
Returns for 3 years | 31.18 | 112.48 | 28% |
Returns for 5 years | 128.34 | 344.88 | 37% |
Returns for 10 years | 28.90 | 29.98 | 96% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPAX | 19.06 | -0.09 | -0.47% |
Saratoga Health & Biotechnology A | |||
DEMAX | 24.36 | -0.29 | -1.18% |
Macquarie Emerging Markets A | |||
IOAPX | 27.86 | -0.35 | -1.24% |
Invesco Main Street All Cap R6 | |||
PICEX | 7.13 | -0.09 | -1.25% |
Virtus SGA Emerging Markets Equity C | |||
AIGIX | 21.39 | -0.30 | -1.38% |
Alger International Opportunities I |